Literature DB >> 10320468

Mood Disorders Secondary to Stroke.

.   

Abstract

Mood disorders associated with stroke have been recognized by clinicians for over 100 years. Recent studies, however, have begun to distinguish whether these mood disorders represent primary disorders or are a secondary consequence of the cerebral infarction. Although poststroke mood disorders share similarities with primary mood disorders in their clinical phenomenology, longitudinal course, and response to treatment, clinical-pathologic correlations during the acute poststroke period have provided a strong argument that these disorders are frequently etiologically linked to the cerebral ischemia. Major depression during the acute stroke period was associated with left frontal and left basal ganglia lesions, while mania was associated with right orbital frontal, basotemporal, basal ganglia, or thalamic lesions. Identification of the mechanism of these disorders will ultimately establish their "secondariness" as well as development of more focused treament strategies.

Entities:  

Year:  1997        PMID: 10320468     DOI: 10.1053/SCNP00200244

Source DB:  PubMed          Journal:  Semin Clin Neuropsychiatry        ISSN: 1084-3612


  3 in total

1.  CD36 deficiency reduces chronic BBB dysfunction and scar formation and improves activity, hedonic and memory deficits in ischemic stroke.

Authors:  Mustafa Balkaya; Il-Doo Kim; Faariah Shakil; Sunghee Cho
Journal:  J Cereb Blood Flow Metab       Date:  2020-05-13       Impact factor: 6.200

2.  The Impact of Pediatric Basal Ganglia Stroke on Mental Health in Children: Report of 2 Cases.

Authors:  Sidrah A Badar; Rupa Radhakrishnan; Meredith R Golomb
Journal:  Child Neurol Open       Date:  2020-12-15

3.  Cerebral White Matter Lesions and Affective Episodes Correlate in Male Individuals with Bipolar Disorder.

Authors:  Armin Birner; Stephan Seiler; Nina Lackner; Susanne A Bengesser; Robert Queissner; Frederike T Fellendorf; Martina Platzer; Stefan Ropele; Christian Enzinger; Petra Schwingenschuh; Harald Mangge; Lukas Pirpamer; Hannes Deutschmann; Roger S McIntyre; Hans-Peter Kapfhammer; Bernd Reininghaus; Eva Z Reininghaus
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.